The Current State of Vaccine Development for Specific Prophylactics of Arenaviral Hemorrhagic Fevers

Presently, the Arenavirus genus (Arenaviridae family) includes 26 individual species of viruses. It is divided into two main groups – Old World arenaviruses and New World arenaviruses. The New World arenaviruses comprise four clades: А, B, C, D; pathogenic for humans New World arenaviruses are attri...

Full description

Bibliographic Details
Main Authors: T. E. Sizikova, V. N. Lebedev, S. I. Syromyatnikova, S. V. Borisevich
Format: Article
Language:Russian
Published: Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe” 2018-07-01
Series:Проблемы особо опасных инфекций
Subjects:
Online Access:https://journal.microbe.ru/jour/article/view/476
_version_ 1797220838222594048
author T. E. Sizikova
V. N. Lebedev
S. I. Syromyatnikova
S. V. Borisevich
author_facet T. E. Sizikova
V. N. Lebedev
S. I. Syromyatnikova
S. V. Borisevich
author_sort T. E. Sizikova
collection DOAJ
description Presently, the Arenavirus genus (Arenaviridae family) includes 26 individual species of viruses. It is divided into two main groups – Old World arenaviruses and New World arenaviruses. The New World arenaviruses comprise four clades: А, B, C, D; pathogenic for humans New World arenaviruses are attributed to clade B. Lassa, Lujo, Machupo, Junin, Guanarito and Sabia viruses are the agents of extremely hazardous hemorrhagic fevers (Lassa hemorrhagic fever, Lujo hemorrhagic fever, Bolivian hemorrhagic fever, Argentinean hemorrhagic fever, Venezuelan hemorrhagic fever, Brazilian hemorrhagic fever, accordingly). These arenaviruses pose a potential threat to national public health due to the possibility of their accidental importation into the territory of the Russian Federation. The vaccination of risk group is the most effective and money-saving means of protection against epidemic spread. Objective of this review is to analyze the specific preparations for arenaviral hemorrhagic fever prevention that are currently under development. Production of live vaccines based on attenuated strains of the agents, the DNA vaccines, vector recombinant vaccines and vaccines on the basis of RNA-replicons is viewed as the main trends in the area. Тhe most important results in the development of effective prophylactic means against arenaviral hemorrhagic fevers are discussed in this paper.
first_indexed 2024-03-08T13:42:59Z
format Article
id doaj.art-e9c15123a93e40d58ffb19f3cbeea728
institution Directory Open Access Journal
issn 0370-1069
2658-719X
language Russian
last_indexed 2024-04-24T12:55:54Z
publishDate 2018-07-01
publisher Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe”
record_format Article
series Проблемы особо опасных инфекций
spelling doaj.art-e9c15123a93e40d58ffb19f3cbeea7282024-04-05T16:47:13ZrusFederal Government Health Institution, Russian Research Anti-Plague Institute “Microbe”Проблемы особо опасных инфекций0370-10692658-719X2018-07-0102303610.21055/0370-1069-2018-2-30-36465The Current State of Vaccine Development for Specific Prophylactics of Arenaviral Hemorrhagic FeversT. E. Sizikova0V. N. Lebedev1S. I. Syromyatnikova2S. V. Borisevich3Federal State Budgetary Institution «48th Central Research Institute» of the Ministry of Defense of the Russian Federation, Sergiev PossadFederal State Budgetary Institution «48th Central Research Institute» of the Ministry of Defense of the Russian Federation, Sergiev PossadFederal State Budgetary Institution «48th Central Research Institute» of the Ministry of Defense of the Russian Federation, Sergiev PossadFederal State Budgetary Institution «48th Central Research Institute» of the Ministry of Defense of the Russian Federation, Sergiev PossadPresently, the Arenavirus genus (Arenaviridae family) includes 26 individual species of viruses. It is divided into two main groups – Old World arenaviruses and New World arenaviruses. The New World arenaviruses comprise four clades: А, B, C, D; pathogenic for humans New World arenaviruses are attributed to clade B. Lassa, Lujo, Machupo, Junin, Guanarito and Sabia viruses are the agents of extremely hazardous hemorrhagic fevers (Lassa hemorrhagic fever, Lujo hemorrhagic fever, Bolivian hemorrhagic fever, Argentinean hemorrhagic fever, Venezuelan hemorrhagic fever, Brazilian hemorrhagic fever, accordingly). These arenaviruses pose a potential threat to national public health due to the possibility of their accidental importation into the territory of the Russian Federation. The vaccination of risk group is the most effective and money-saving means of protection against epidemic spread. Objective of this review is to analyze the specific preparations for arenaviral hemorrhagic fever prevention that are currently under development. Production of live vaccines based on attenuated strains of the agents, the DNA vaccines, vector recombinant vaccines and vaccines on the basis of RNA-replicons is viewed as the main trends in the area. Тhe most important results in the development of effective prophylactic means against arenaviral hemorrhagic fevers are discussed in this paper.https://journal.microbe.ru/jour/article/view/476hemorrhagic feversarenaviruseslassa virusmachupo virusjunin virusspecific prophylacticslive vaccinesvector recombinant vaccinesrna-repliconsdna vaccines
spellingShingle T. E. Sizikova
V. N. Lebedev
S. I. Syromyatnikova
S. V. Borisevich
The Current State of Vaccine Development for Specific Prophylactics of Arenaviral Hemorrhagic Fevers
Проблемы особо опасных инфекций
hemorrhagic fevers
arenaviruses
lassa virus
machupo virus
junin virus
specific prophylactics
live vaccines
vector recombinant vaccines
rna-replicons
dna vaccines
title The Current State of Vaccine Development for Specific Prophylactics of Arenaviral Hemorrhagic Fevers
title_full The Current State of Vaccine Development for Specific Prophylactics of Arenaviral Hemorrhagic Fevers
title_fullStr The Current State of Vaccine Development for Specific Prophylactics of Arenaviral Hemorrhagic Fevers
title_full_unstemmed The Current State of Vaccine Development for Specific Prophylactics of Arenaviral Hemorrhagic Fevers
title_short The Current State of Vaccine Development for Specific Prophylactics of Arenaviral Hemorrhagic Fevers
title_sort current state of vaccine development for specific prophylactics of arenaviral hemorrhagic fevers
topic hemorrhagic fevers
arenaviruses
lassa virus
machupo virus
junin virus
specific prophylactics
live vaccines
vector recombinant vaccines
rna-replicons
dna vaccines
url https://journal.microbe.ru/jour/article/view/476
work_keys_str_mv AT tesizikova thecurrentstateofvaccinedevelopmentforspecificprophylacticsofarenaviralhemorrhagicfevers
AT vnlebedev thecurrentstateofvaccinedevelopmentforspecificprophylacticsofarenaviralhemorrhagicfevers
AT sisyromyatnikova thecurrentstateofvaccinedevelopmentforspecificprophylacticsofarenaviralhemorrhagicfevers
AT svborisevich thecurrentstateofvaccinedevelopmentforspecificprophylacticsofarenaviralhemorrhagicfevers
AT tesizikova currentstateofvaccinedevelopmentforspecificprophylacticsofarenaviralhemorrhagicfevers
AT vnlebedev currentstateofvaccinedevelopmentforspecificprophylacticsofarenaviralhemorrhagicfevers
AT sisyromyatnikova currentstateofvaccinedevelopmentforspecificprophylacticsofarenaviralhemorrhagicfevers
AT svborisevich currentstateofvaccinedevelopmentforspecificprophylacticsofarenaviralhemorrhagicfevers